Table 5 Prevalence of 44 chronic diseases in type 2 diabetes patients
Chronic disease | Overall (%) | Males (%) | Females (%) | Differences between sexes |
|---|---|---|---|---|
Hypertension | 73.71% | 73.23% | 73.54% | <0.001 |
Dyspepsia | 13.81% | 11.36% | 16.70% | <0.001 |
Prostatic hypertrophy | --- | 13.48% | --- | --- |
Anxiety | 12.75% | 8.54% | 18.10% | <0.001 |
Degenerative joint disease | 11.72% | 7.79% | 15.79% | 0.002 |
Atrial Fibrillation | 10.40% | 12.15% | 8.54% | <0.001 |
Depression | 9.77% | 5.47% | 14.78% | <0.001 |
Malignant neoplasms | 8.86% | 11.17% | 6.96% | <0.001 |
Chronic heart disease, other | 8.57% | 10.77% | 6.09% | <0.001 |
Emphysema, chronic bronchitis, COPD | 8.23% | 12.09% | 4.50% | <0.001 |
Hypothyroidism | 6.22% | 2.31% | 11.31% | <0.001 |
Low back pain | 5.82% | 4.34% | 7.65% | <0.001 |
Dementia | 5.05% | 4.17% | 5.80% | <0.001 |
Osteoporosis | 4.46% | 0.83% | 8.26% | <0.001 |
Gout | 3.72% | 5.75% | 1.44% | <0.001 |
Deafness | 3.50% | 3.52% | 3.41% | 0.071 |
Asthma (currently under treatment) | 3.26% | 1.99% | 4.78% | <0.001 |
Chronic hepatopancreatic diseases | 3.25% | 3.91% | 2.29% | <0.001 |
Diverticular disease | 2.80% | 2.58% | 3.03% | <0.001 |
Peripheral vascular disease | 2.50% | 3.96% | 0.97% | <0.001 |
Rheumatoid arthritis and others | 2.40% | 2.10% | 2.78% | <0.001 |
Errors of metabolism and chromosomopathies | 2.15% | 2.51% | 1.69% | <0.001 |
Parkinson’s disease | 1.88% | 1.83% | 1.99% | <0.001 |
Muscular dystrophy or paralysis | 1.53% | 1.73% | 1.33% | 0.005 |
Schizophrenia | 1.50% | 1.24% | 1.81% | <0.001 |
Chronic constipation | 1.07% | 1.04% | 1.17% | <0.001 |
Alcohol abuse | 1.00% | 1.46% | 0.40% | <0.001 |
Viral Hepatitis | 0.81% | 0.84% | 0.71% | <0.001 |
Psoriasis or eczema | 0.76% | 0.87% | 0.63% | <0.001 |
Immunological diseases | 0.63% | 0.66% | 0.63% | 0.245 |
Irritable bowel syndrome | 0.60% | 0.38% | 0.87% | <0.001 |
Bronchiectasis | 0.59% | 0.75% | 0.47% | 0.003 |
Chronic Haematological Diseases | 0.58% | 0.60% | 0.59% | 0.085 |
Epilepsy (currently under treatment) | 0.55% | 0.58% | 0.53% | 0.457 |
Inflammatory bowel disease | 0.50% | 0.52% | 0.47% | 0.040 |
Post-transplant state | 0.37% | 0.44% | 0.26% | <0.001 |
Chronic Sinusitis | 0.26% | 0.25% | 0.28% | 0.891 |
Learning Disabilities | 0.13% | 0.11% | 0.17% | 0.115 |
HIV | 0.12% | 0.15% | 0.06% | <0.001 |
Migraine | 0.11% | 0.04% | 0.23% | <0.001 |
Substance Abuse | 0.11% | 0.14% | 0.05% | <0.001 |
Multiple sclerosis | 0.07% | 0.05% | 0.10% | 0.033 |
Anorexia, bulimia | 0.03% | 0.01% | 0.06% | <0.001 |
ADHD | 0.005% | 0.002% | 0.01% | 0.311 |